Dudediligence.

Decoy Therapeutics Inc

DCOYNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$972,121Sep ’24−$1.5MDec ’24−$1.7MMar ’25−$957,825Jun ’25−$873,467Sep ’25$16.1MDec ’25−$2.2MMar ’26−$2.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.8M$0.00none on filenone on filenone on file
Operating income−$12.8M−$31.8M−$12.9M−$5.7M−$12.6M
Net income−$12.8M−$31.6M−$12.5M−$5.6M$12.5M
Operating cash flow−$10.2M−$17.6M−$12.8M−$4.5M−$4.8M
Free cash flow−$10.2Mnone on filenone on file−$4.5M−$5.4M
Cash$29.2M$12.1M$5.9M$2.4M$10.7M
Shares outstanding1.8M2.3M492.3K1.4M97.0K